CPC A61K 31/5685 (2013.01) [C07J 1/0025 (2013.01)] | 16 Claims |
1. A stable pharmaceutical composition comprising (17-β)-3-Oxoandrost-4-en-17-yl tridecanoate and a pharmaceutically acceptable carrier suitable for administration to a human subject in need of (17-β)-hydroxy androst-4-en-3-one, said carrier comprising oleic acid, ascorbyl palmitate, polyoxyl 40 hydrogenated castor oil and glyceryl palmitostearate, wherein when stored for at least 1 month at no less than 25° C. and no less than 60% relative humidity the composition is substantially free of (17-β)-3-Oxoandrost-4-en-17-yl tridecanoate impurities.
|